Eric d'Esparbes
2014 - Innoviva
In 2014, Eric d'Esparbes earned a total compensation of $2.1M as Senior Vice President and Chief Financial Officer at Innoviva.
Compensation breakdown
| Non-Equity Incentive Plan | $80,000 |
|---|---|
| Salary | $87,803 |
| Stock Awards | $1,883,417 |
| Other | $15,328 |
| Total | $2,066,548 |
d'Esparbes received $1.9M in stock awards, accounting for 91% of the total pay in 2014.
d'Esparbes also received $80K in non-equity incentive plan, $87.8K in salary and $15.3K in other compensation.
Rankings
In 2014, Eric d'Esparbes' compensation ranked 4,391st out of 13,032 executives tracked by ExecPay. In other words, d'Esparbes earned more than 66.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,391 out of 13,032 | 66th |
Division Manufacturing | 1,562 out of 4,966 | 69th |
Major group Chemicals And Allied Products | 515 out of 1,686 | 70th |
Industry group Drugs | 396 out of 1,365 | 71st |
Industry Pharmaceutical Preparations | 315 out of 1,043 | 70th |
Source: SEC filing on March 25, 2016.
d'Esparbes' colleagues
We found six more compensation records of executives who worked with Eric d'Esparbes at Innoviva in 2014.
2014
Rick Winningham
Innoviva
Chief Executive Officer
2014
Michael Aguiar
Innoviva
Chief Executive Officer
2014
Mathai Mammen
Innoviva
Former Senior Vice President, Research & Development
2014
Leonard Blum
Innoviva
Former Senior Vice President and Chief Commercial Officer
2014
George Abercrombie
Innoviva
Senior Vice President and Chief Commercial Officer
2014
Theodore Witek
Innoviva
Chief Scientific Officer
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019